| SL550181 |
HEK293T cells stably expressing human ACE2 (NM_021804.2) and TMPRSS2(NM_005656.3), 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550183 |
Human skin fibroblasts stably expressing SV40 large T antigen, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550187 |
Human adipose-derived mesenchymal stem cell line stably expressing SV40 large T antigen, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550191 |
HepG2 cell line dual-labeled with luciferase and GFP, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550182 |
Human gall bladder epithelial cell stably expressing SV40 large T antigen, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550185 |
Human bone marrow-derived mesenchymal stem cell line stably expressing SV40 large T antigen, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550188 |
Human umbilical cord-derived mesenchymal stem cell line stably expressing SV40 large T antigen, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550189 |
Human umbilical cord-derived mesenchymal stem cell line stably expressing SV40 large T antigen and hTERT gene, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550190 |
Neuro-2a mouse neuroblastoma cell line dual-labeled with luciferase and GFP, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550186 |
Human bone marrow-derived mesenchymal stem cell stably expressing SV40 large T antigen and hTERT gene, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550201 |
GFP-labeled Panc 10.05 cancer cell line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550204 |
GFP-labeled KATO III cancer cell line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550208 |
HEK293/induced Cas9-AAVS1-hyg, single clone, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550215 |
HCT116/BRAF V600E Homozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550193 |
786-O human kidney adenocarcinoma cell line dual-labeled with luciferase and GFP, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550197 |
GFP-labeled COLO 205 cancer cell line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550200 |
GFP-labeled PLC/PRF/5 cancer cell line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550206 |
HEK293/RFP-CopGFP-AAVS1-Puro, single clone, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550195 |
A549 human lung carcinoma cell line dual-labeled with luciferase and GFP, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550196 |
GFP-labeled LoVo cancer cell line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550198 |
GFP-labeled SNU-475 cancer cell line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550203 |
GFP-labeled BxPC-3 cancer cell line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550205 |
Human ectopic endometrium epithelium cell line stably expressing SV40 large T antigen, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550199 |
GFP-labeled C3A cancer cell line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550202 |
GFP-labeled CFPAC-1 cancer cell line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550214 |
HCT116/EGFR_L858R Heterozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550226 |
HCT116/KRAS G12C Heterozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550207 |
Neuro2a/RFP-CopGFP-Rosa26-puro, single clone, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550209 |
Neuro2a/inducible Cas9-Rosa26-hyg, single clone, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550217 |
HCT116/EGFR dE746-A750 Homozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550218 |
HCT116/EGFR dE746-A750 Heterozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550219 |
HCT116/BRAF V600E Homozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550210 |
HCT116/CMV-RFP-GFP-Puro-AAVS1, single clone, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550211 |
HCT116/dE746-A750 Homozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550212 |
HCT116/EGFR_dE746-A750 Heterozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550213 |
HCT116/EGFR_L858R Homozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550216 |
HCT116/BRAF V600E Heterozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550222 |
HCT116/cKIT D816V Heterozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550225 |
HCT116/KRAS G12D Homozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550231 |
HCT116/NRAS Q61K Heterozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550221 |
HCT116/cKIT D816V Homozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550224 |
HCT116/KRAS G12C Homozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550229 |
HCT116/PIK3CA E545 Homozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550232 |
NRAS G12D Homozygous HCT116 Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550220 |
HCT116/BRAF V600E Heterozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550223 |
HCT116/KRAS G13D Heterozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550227 |
HCT116/PIK3CA E545K Homozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550228 |
HCT116/PIK3CA E545K Heterozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550230 |
HCT116/PIK3CA E545 Heterozygote cell line, with spike-in, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
| SL550235 |
EGFR G719S Heterozygous HCT116 Cancer Biomarker Mutant Cell Line, 2×10^6 cells |
1 vial |
Detail
|
Inquire |
